Baina, Marcel Tapsou
Djontu, Jean Claude
Lissom, Abel
Doulamo, Naura Veil Assioro
Umuhoza, Dieu Merci
Ntabi, Jacque Dollon Mbama
Vouvoungui, Christevy Jeanney
Boumpoutou, Reauchelvy Kamal
Mayela, Jolivet
Diafouka-Kietela, Steve
Nguimbi, Etienne
Ntoumi, Francine
Article History
Received: 11 April 2023
Accepted: 18 August 2023
First Online: 25 August 2023
Declarations
:
: The study protocol was reviewed and approved by the Institutional Ethics Committee of the Fondation Congolaise pour la Recherche Médicale (ethics clearance N° 03 I/CEÆCRNI/2020). Participation in the study was voluntary with written informed consent from each adult individual or parents (guardians) for participants less than 18 years old. All malaria positive patients were treated by the physician with artemisinin-based combination therapy (ACT) according to the WHO and national malaria control program guidelines.
: The authors declare no competing interests.